Kepler Capital analyst Arsene Guekam maintained a Hold rating on Galapagos (NASDAQ:GLPG) on Tuesday, setting a price target of EUR79, which is approximately 71.08% above the present share price of $52.3.
Guekam expects Galapagos to post earnings per share (EPS) of -$0.99 for the fourth quarter of 2021.
The current consensus among 4 TipRanks analysts is for a Hold rating of shares in Galapagos, with an average price target of $71.03.
The analysts price targets range from a high of $89.48 to a low of $56.63.
In its latest earnings report, released on 09/30/2021, the company reported a quarterly revenue of $64.19 million and a net profit of -$78.2 million. The company's market cap is $3.43 billion.
According to TipRanks.com, Kepler Capital analyst Arsene Guekam is currently ranked with 2 stars on a 0-5 stars ranking scale, with an average return of 1.5% and a 35.90% success rate.
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research and Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.